major glp 1 drugs GLP-1 may fight addiction across every substance, according to a study of 600,000 people The expanding landscape of GLP-1

The global invisible orthodontics market size is calculated at USD 7.7 billion in 2024, grows to USD 9.91 billion in 2025, and is projected to reach around USD 96.27 billion by 2034

Thyroid Tumors : Wegovy carries a potential risk for thyroid cancer, although the exact impact on humans remains uncertain

It is important to note that randomized trials typically involve a highly selective group of individuals who do not accurately reflect the general population with T2DM

Percentage of Semaglutide Users Reporting Vision Loss or Partial Blindness Study results indicate an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) in patients using semaglutide for Type 2 diabetes and obesity